The Use of Antiarrhythmic Drugs in Pediatrics
Launched by ASSIUT UNIVERSITY · Feb 20, 2024
Trial Information
Current as of July 13, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "The Use of Antiarrhythmic Drugs in Pediatrics," is focused on studying the effects of antiarrhythmic medications in children and young people who have heart rhythm problems. The trial is taking place at Assiut University Children's Hospital and aims to understand how these drugs work and any potential side effects they may cause in young patients. It is important to note that this study has not started recruiting participants yet.
To be eligible for this trial, children between the ages of 1 month and 18 years who are admitted to the cardiology unit at Assiut University Hospital and are receiving antiarrhythmic drugs can participate. However, patients who are taking other types of medications will not be included in the study. If you or someone you know qualifies, participants will have the chance to contribute to important research that could improve treatment for children with heart rhythm issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All Patients with Arrhythmic cardiac diseases admitted at cardiology unit Assiut University Hospital aged from 1 month to 18 years.
- • All patient receiving antiarrhythmic drugs admitted to Assiut University Hospital for Children.
- Exclusion Criteria:
- • • Any patient on drugs other than antiarrhythmics.
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported